Laura S Angelo

Marker Therapeutics, Inc.

NIH Rank #23620
  • Early Career

NIH Funding · FY2024

Total Funding
$664.8K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#23,620
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $664.8K across 1 grant · National rank #23620.

Top grants by award amount

Laura S Angelo's NIH grant portfolio, ranked by award amount.

  • 5R44CA285177-02R44
    Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant
    $664.8K
    award amount

Affiliation

Institutions that have administered grants for Laura S Angelo.

Affiliated with Marker Therapeutics, Inc. (TX).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Marker Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding

Related investigators

Other NIH-funded PIs frequently associated with Laura S Angelo.